Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
5,439 JPY | +1.95% | +16.58% | +40.39% |
Apr. 30 | Remsons, Daiichi Infotainments Form Joint Venture | MT |
Apr. 29 | AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement | MT |
ETFs positioned on Daiichi Sankyo Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
25.16% | 15 M€ | +11.47% | ||
4.18% | 251 M€ | +13.17% | ||
3.32% | 174 M€ | -.--% | - | |
3.32% | 51 M€ | -.--% | - | |
3.24% | 15 M€ | +16.45% | ||
2.78% | 81 M€ | +15.72% | ||
2.69% | 57 M€ | +21.11% | ||
2.19% | 14 M€ | +18.86% | ||
2.13% | 73 M€ | +18.87% | ||
1.96% | 10,207 M€ | +16.22% | ||
1.95% | 5,115 M€ | +15.75% | ||
1.71% | 26 M€ | +21.71% | ||
1.68% | 16,729 M€ | +13.72% | - | |
1.64% | 31,732 M€ | +14.69% | - | |
1.63% | 1,198 M€ | +14.04% | - | |
1.42% | 66,066 M€ | +16.18% | - | |
1.42% | 144,586 M€ | +16.06% | ||
1.42% | 20,721 M€ | +15.08% | - | |
1.35% | 18 M€ | +16.15% | - | |
1.29% | 4 M€ | +16.67% | ||
1.08% | 60 M€ | +15.56% | ||
0.99% | 67,864 M€ | +14.60% | ||
0.69% | 4 M€ | -.--% | - | |
0.68% | 717 M€ | +5.83% | ||
0.44% | 26 M€ | +2.32% | - | |
0.30% | 10 M€ | -3.35% | - | |
0.30% | 36 M€ | +1.38% | - | |
0.25% | 7 M€ | +2.58% | - | |
0.23% | 276 M€ | +11.40% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+40.39% | 65.32B | |
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- 4568 Stock
- Funds and ETFs Daiichi Sankyo Co., Ltd.